Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

Nrf2/HO-1 activator 1

Nrf2/HO-1 activator 1 (Compound 24) is a potent Nrf2/HO-1 activator, neuroprotective agent. Nrf2/HO-1 activator 1 shows neuroprotective and antioxidant activities. Nrf2/HO-1 activator 1 can be used in Parkinson's disease (PD) research[1].

Product Specifications

CAS Number

[2883506-60-1]

UNSPSC

12352005

Target

Akt; ERK; JNK; Keap1-Nrf2; Reactive Oxygen Species (ROS)

Type

Reference compound

Related Pathways

Immunology/Inflammation; MAPK/ERK Pathway; Metabolic Enzyme/Protease; NF-κB; PI3K/Akt/mTOR; Stem Cell/Wnt

Applications

Neuroscience-Neurodegeneration

Field of Research

Neurological Disease

Assay Protocol

https://www.medchemexpress.com/nrf2-ho-1-activator-1.html

Solubility

10 mM in DMSO

Smiles

O=C1C(C2=CC=C(OC)C=C2)=COC3=C1C4=C(C=CC(C)(C)O4)C(O)=C3

Molecular Formula

C21H18O5

Molecular Weight

350.36

References & Citations

[1]Qili Lu, et al. Novel cudraisoflavone J derivatives as potent neuroprotective agents for the treatment of Parkinson's disease via the activation of Nrf2/HO-1 signaling. Eur J Med Chem. 2022 Nov 15;242:114692.

Shipping Conditions

Room temperature

Scientific Category

Reference compound1

Clinical Information

No Development Reported

Curated Selection

Explore Other Products

Discover premium biology products from our extensive collection of 20M+ items

Mouse UPF0606 protein KIAA1549, Kiaa1549 ELISA KIT
ELI-13322m 96 Tests

Mouse UPF0606 protein KIAA1549, Kiaa1549 ELISA KIT

Ask
View Details
LY 2955303
5984/5 5 mg

LY 2955303

Ask
View Details
RNU7-22P siRNA Oligos set (Human)
40531171 3x 5 nmol

RNU7-22P siRNA Oligos set (Human)

Ask
View Details
Mouse Monoclonal P-Selectin/CD62P Antibody (Psel.KO.2.7) [PE/Cy5.5]
NB100-65392PECY55 0.1 mL

Mouse Monoclonal P-Selectin/CD62P Antibody (Psel.KO.2.7) [PE/Cy5.5]

Ask
View Details
Epratuzumab
HY-P99289-01 1 mg

Epratuzumab

Ask
View Details
Epratuzumab
HY-P99289-02 5 mg

Epratuzumab

Ask
View Details